Emcure Pharmaceuticals (NSE:EMCURE) Interest Expense : ₹-1,351 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Emcure Pharmaceuticals's interest expense for the three months ended in Dec. 2024 was ₹ -318 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-1,351 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Emcure Pharmaceuticals's Operating Income for the three months ended in Dec. 2024 was ₹ 2,649 Mil. Emcure Pharmaceuticals's Interest Expense for the three months ended in Dec. 2024 was ₹ -318 Mil. Emcure Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2024 was 8.34. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Emcure Pharmaceuticals Interest Expense Historical Data

The historical data trend for Emcure Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Interest Expense Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Interest Expense

-1,549.41

-1,614.54

-1,916.05

-2,287.74

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial			-589.43	-606.47	-571.13	-462.21	-317.78

Emcure Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,351 Mil.

Emcure Pharmaceuticals (NSE:EMCURE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Emcure Pharmaceuticals's Interest Expense for the three months ended in Dec. 2024 was ₹-318 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹2,649 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Emcure Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	2649.36	/	-317.78
	=	8.34

The higher the ratio, the stronger the company's financial strength is.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Interest Expense

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines